Overview

Descemet Endothelial Thickness Comparison Trial

Status:
Active, not recruiting
Trial end date:
2023-05-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
Phase:
Phase 4
Details
Lead Sponsor:
Oregon Health and Science University
Winston Chamberlain, MD, PhD
Collaborators:
Stanford University
University of California, San Francisco
Treatments:
Levofloxacin
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Ofloxacin
Oxymetazoline
Phenylephrine
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Tropicamide